Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-031038

Chief Legal Officer sold 20,416 shares at an average $23.45 ($478,845)

  • Chief Legal Officer acquired 20,416 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ali-Jackson Kamil · Chief Legal Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-06 Exercise or conversion : show line 1 in the form +15,000 $10.66 $159,900 158,618 D
2021-05-06 Sale : show line 2 in the form −11,898 $23.32 $277,438 146,720 D
2021-05-06 Sale : show line 3 in the form −3,102 $23.86 $74,016 143,618 D
2021-05-07 Exercise or conversion : show line 4 in the form +5,416 $10.66 $57,735 149,034 D
2021-05-07 Sale : show line 5 in the form −3,316 $23.23 $77,016 145,718 D
2021-05-07 Sale : show line 6 in the form −2,100 $23.99 $50,376 143,618 D
Open-market sales · 20,416 sh · avg $23.45 · $478,845

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-05-06 Exercise or conversion : show line 7 in the form Employee Stock Option (Right to Buy) −15,000 5,416 D
2021-05-07 Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Buy) −5,416 0 D
Loading xslF345X03/doc4.xml…